Trademark Overview
On Friday, July 10, 2026, a trademark application was filed for KF-OMICS with the United States Patent and Trademark Office. The USPTO has given the KF-OMICS trademark a serial number of 99934385. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, July 10, 2026. This trademark is owned by Kessler Foundation Inc.. The KF-OMICS trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Downloadable computer software using artificial intelligence and machine learning for analyzing multimodal biomedical data, including clinical, neuroimaging, blood-based biomarker, genetic, neurophysiological, and neuropsychological data; downloadable computer software featuring topological and relational modeling of patient data using mechanistic and anatomical constraints to generate unified biological representations for biomarker discovery, patient stratification, identification of biological subtypes, latent phenotypes, disease endotypes, probabilistic patient classification, treatment response modeling, precision medicine research, and prediction of clinical and cognitive outcomes in traumatic brain injury and other neurological disorders.
Software as a service (SAAS) services featuring artificial intelligence and machine learning software for analyzing multimodal biomedical data, including clinical, neuroimaging, blood-based biomarker, genetic, neurophysiological, and neuropsychological data; software as a service (SAAS) services featuring topological and relational modeling of patient data using mechanistic and anatomical constraints to generate unified biological representations for biomarker discovery, patient stratification, identification of biological subtypes, latent phenotypes, disease endotypes, probabilistic patient classification, treatment response modeling, precision medicine research, and prediction of clinical and cognitive outcomes in traumatic brain injury and other neurological disorders.
